Sandborn William

Statistics

Publications

Citations

H-Index

Active since

1990

Affiliations

University of California San Diego(Current)

Sandborn William is an author at University of California San Diego specializing in inflammatory bowel disease therapy, pharmacotherapy, and ulcerative colitis pharmacotherapy.

Publications per year

1990–2020

Publications

Archaebacterial ATPases: Relationship to Other Ion-Translocating ATPase Families Examined in Terms of Immunological Cross-Reactivity1

Jin Konishi, Kimitoshi Denda, Tairo Oshima et al. · The Journal of Biochemistry · 1990 · 24 citations

Life Sciences, Biochemistry, Molecular Biology +9

O-001 Budesonide MMX® 9 mg for Inducing Remission in Patients With Mild-to-Moderate Ulcerative Colitis Not Adequately Controlled With Oral 5-ASAs

Rubin David, Cohen Russell, Sandborn William et al. · Inflammatory Bowel Diseases · 2014 · 15 citations · Full text

Pharmacy, Pharmacotherapy, Gastrointestinal Pharmacotherapy +14

P025 Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study

Sandborn William, DʼHaens Geert, Wolf Doug et al. · The American Journal of Gastroenterology · 2020 · 15 citations

Medicine, Immunology, Pharmacotherapy +15

Etrolizumab as Induction Therapy in Moderate to Severe Crohnʼs Disease: Results From BERGAMOT Cohort 1

Sandborn William, P.A.C. Julian, Jones Jennifer et al. · The American Journal of Gastroenterology · 2018 · 10 citations

Pharmacy, Clinical Sciences, Pharmacotherapy +17

1–4 of 4